SCHEMBL7099166

SCHEMBL7099166

CC(=O)C(=O)C(=O)C(C)=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.60
THPO P40225 1/20 0.60
LMNA P02545 2/20 0.50
CA4 P22748 2/20 0.46
FFAR3 O14843 1/20 0.46
LCK P06239 1/20 0.46
FYN P06241 1/20 0.46
CA1 P00915 2/20 0.42
BLM P54132 2/20 0.42
PMP22 Q01453 2/20 0.42
ALOX15 P16050 1/20 0.42
THRB P10828 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
ALDH1A1 P00352 5/20 0.36
TDP1 Q9NUW8 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30849212 0.95 TSHR (0.55) TSHRTHPOLMNACA4FFAR3
SCHEMBL15656411 0.95 TSHR (0.55) TSHRTHPOLMNACA4FFAR3
SCHEMBL30724539 0.95 TSHR (0.55) TSHRTHPOLMNACA4FFAR3
SCHEMBL556991 0.89
Ammonia Solution, Strong SCHEMBL11244185 0.84
Acetone SCHEMBL9771958 0.84 LMNA (0.60) TSHRTHPOLMNACA4FFAR3
SCHEMBL28784840 0.84
SCHEMBL31106422 0.84
SCHEMBL11053648 0.83 TSHR (0.43) TSHRTHPOLMNACA4FFAR3
Acetamide SCHEMBL28551614 0.77 LMNA (0.67) TSHRTHPOLMNACA4FFAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030162199-A1 Reversible chemical modification of nucleic acids and improved method for nucleic acid hybridization BIOLINK PARTNERS, INC. 2003-08-28 US claimed
CN-108578754-A A kind of preparation method of the far infrared bamboo fiber dressing containing sugar 广东泰宝医疗器械技术研究院有限公司 2018-09-28 CN disclosed
US-20170057962-A1 NON-FULLERENE ELECTRON ACCEPTORS FOR ORGANIC PHOTOVOLTAIC DEVICES UNIVERSITY OF WASHINGTON (US) 2017-03-02 US disclosed
CN-102981365-B Copolymer, resin composition, spacer for display panel, planarization film, thermosetting protective film, microlens, and process for producing copolymer TOKYO OHKA KOGYO CO LTD 2014-12-17 CN disclosed
CN-102977259-B Copolymer, resin composition, spacer for display panel, planarization film, thermosetting protective film, microlens, and process for producing copolymer TOKYO OHKA KOGYO CO LTD 2014-12-17 CN disclosed
CN-101903426-B Copolymer, resin composition, spacer for display panel, planarizing film, thermosetting protective film, microlens, and method for producing copolymer TOKYO OHKA KOGYO CO LTD 2013-05-08 CN disclosed
CN-102981365-A Copolymer, resin composition, spacer for display panel, planarization film, thermosetting protective film, microlens, and process for producing copolymer TOKYO OHKA KOGYO CO LTD 2013-03-20 CN disclosed
CN-102977259-A Copolymer, resin composition, spacer for display panel, planarization film, thermosetting protective film, microlens, and process for producing copolymer TOKYO OHKA KOGYO CO LTD 2013-03-20 CN disclosed
CN-101903426-A Copolymer, resin composition, spacer for display panel, planarizing film, thermosetting protective film, microlens, and method for producing copolymer TOKYO OHKA KOGYO CO LTD 2010-12-01 CN disclosed
US-20030162199-A1 Reversible chemical modification of nucleic acids and improved method for nucleic acid hybridization BIOLINK PARTNERS, INC. 2003-08-28 US disclosed
US-4761476-A Compounds formed by the reaction of piperazine, and derivatives thereof, with glyoxal, and derivatives thereof THE DOW CHEMICAL COMPANY (US) 1988-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170057962-A1 NON-FULLERENE ELECTRON ACCEPTORS FOR ORGANIC PHOTOVOLTAIC DEVICES VDAC1, SLC19A1, SLC46A1 TSHR 4732/4885THPO 4432/4885LMNA 4109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.